Internal Medicine · Bayamon, PR
NPI
1295743367
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
Instituto San Pablo, Suite 507 Calle Santa Cruz #66
Bayamon, PR, 00961
Phone (787) 740-2010
Medicare paid, 2024
$12K
190 services
Medicare patients, 2024
42
Average age 78
Drug cost, 2024
$1.2M
12,051 prescriptions
Company payments, 2025
$158
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ernesto X Marrero de Gracia was code 99232 (hospital e&m - subsequent), 94 times for 18 patients. In total Ernesto X Marrero de Gracia billed 190 services in 7 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 94 | 18 | $58.24 | $5,475 |
| 99213 Office E&M - Established | Office | 72 | 27 | $58.79 | $4,233 |
By year: 2022 $13K for 215 services; 2023 $7,729 for 131 services; 2024 $12K for 190 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ernesto X Marrero de Gracia prescribed most often to Medicare patients was Atorvastatin Calcium, with 751 prescriptions and refills. In total Ernesto X Marrero de Gracia wrote 12,051 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 751 | 2,117 | 244 | $9,228 |
| Gabapentin Generic | 639 | 1,327 | 173 | $9,030 |
| Losartan Potassium Generic | 442 | 1,223 | 146 | $6,437 |
| Metoprolol Succinate Generic | 405 | 1,067 | 148 | $8,797 |
| Metformin Hcl Generic | 394 | 1,087 | 122 | $3,066 |
| Levothyroxine Sodium Generic | 389 | 1,027 | 121 | $6,649 |
| Amlodipine Besylate Generic | 361 | 1,017 | 124 | $3,388 |
| Omeprazole Generic | 316 | 569 | 80 | $2,875 |
| Synthroid Levothyroxine Sodium | 296 | 700 | 82 | $33K |
| Simvastatin Generic | 278 | 808 | 91 | $2,893 |
| Rosuvastatin Calcium Generic | 266 | 640 | 88 | $3,768 |
| Famotidine Generic | 257 | 502 | 76 | $2,639 |
| Irbesartan Generic | 254 | 734 | 85 | $8,852 |
| Pantoprazole Sodium Generic | 232 | 444 | 73 | $2,895 |
| Lantus Insulin Glargine,hum.Rec.Anlog | 191 | 268 | 44 | $18K |
Brand drugs: 1,844 claims; generic drugs: 10,111 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ernesto X Marrero de Gracia $158 ($158 in general payments such as food, travel and fees) from 3 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $106.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $106 |
| Pbg Puerto Rico LLC | 1 | $28.44 |
| Merck Sharp & Dohme LLC MRK | 1 | $23.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.